Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan.
Nephron Exp Nephrol. 2012;122(1-2):13-22. doi: 10.1159/000346954. Epub 2013 Feb 26.
BACKGROUND/AIMS: To examine the role of the angiotensin II (ATII) type 1a receptor (AT1-R) pathway in renal tissue damage and repair, we investigated reversible glomerular injury in a mouse model of habu snake venom (HSV)-induced glomerulonephritis using AT1-R-deficient (AT1a-/-) mice and AT1-R antagonist-treated mice.
Experimental glomerulonephritis was induced by single administration of HSV to AT1a(+/+) mice (HSV group) and AT1a(-/-) mice (KO-HSV group) and AT1-R antagonist-treated BL6 mice (HSV-ARB group). Morphological change and expression levels of type IV collagen, CD31, and vascular endothelial growth factor (VEGF) were analyzed.
The HSV group showed increased mesangial matrix expansion on day 7, which returned to preinjection levels by day 56, while mes-angial matrix expansion and increased type IV collagen expression were seen throughout days 7 to 56 in the KO-HSV group. The KO-HSV group showed fewer CD31-positive capillary loops and a marked decrease in the number of VEGF-positive cells in the glomeruli than the HSV group. VEGF administration to the KO-HSV group facilitated glomerular capillary repair and reconstruction. The HSV-ARB group showed the same delay in glomerular repair as that seen in the KO-HSV group.
Our results indicate that blocking of the ATII-AT1R pathway delays glomerular repair via angiogenesis inhibition, followed by reduced induction of VEGF.
背景/目的:为了研究血管紧张素 II (ATII) 型 1a 受体 (AT1-R) 通路在肾组织损伤和修复中的作用,我们利用眼镜蛇蛇毒 (HSV) 诱导的肾小球肾炎小鼠模型,研究了 AT1-R 缺陷 (AT1a-/-) 小鼠和 AT1-R 拮抗剂治疗小鼠的可逆性肾小球损伤。
通过单次给予 HSV 诱导 AT1a(+/+) 小鼠 (HSV 组) 和 AT1a(-/-) 小鼠 (KO-HSV 组) 以及 AT1-R 拮抗剂治疗的 BL6 小鼠 (HSV-ARB 组),建立实验性肾小球肾炎。分析形态变化以及 IV 型胶原、CD31 和血管内皮生长因子 (VEGF) 的表达水平。
HSV 组在第 7 天出现系膜基质扩张增加,第 56 天恢复至注射前水平,而 KO-HSV 组在第 7 至 56 天期间系膜基质扩张和 IV 型胶原表达均增加。KO-HSV 组肾小球内 CD31 阳性毛细血管环较少,VEGF 阳性细胞数明显减少。VEGF 给药促进了 KO-HSV 组肾小球毛细血管的修复和重建。HSV-ARB 组的肾小球修复延迟与 KO-HSV 组相同。
我们的研究结果表明,阻断 ATII-AT1R 通路通过抑制血管生成,减少 VEGF 的诱导,从而延迟肾小球修复。